| Line 182: | Line 182: | ||
=Suggestions to add to this page= | =Suggestions to add to this page= | ||
[https://reason.com/wp-content/uploads/2022/12/Rodu-Plurphanswat-CrossSec-Studies-IAEM-2022.pdf Cross‑sectional e‑cigarette studies are unreliable without timing of exposure and disease diagnosis] | |||
[https://reason.com/2022/12/13/diseases-that-studies-linked-to-e-cigarettes-generally-were-diagnosed-before-subjects-began-vaping/ Diseases That Studies Linked to E-Cigarettes Generally Were Diagnosed Before Subjects Began Vaping] | |||
[https://reason.com/2023/01/04/a-medical-journal-retracts-a-2022-study-that-linked-vaping-to-cancer/ A Medical Journal Retracts a 2022 Study That Linked Vaping to Cancer] | |||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506048/ Critical Review of the Recent Literature on Organic Byproducts in E-Cigarette Aerosol Emissions] | |||
[[File:Retracted 2.png|center|]] | [[File:Retracted 2.png|center|]] | ||
edits